Toggle Health Problems and D

Teens with low vitamin D were 4.2 X more likely to have metabolic syndrome – CASPIAN-V Nov 2021

Association of vitamin D status and cardio-metabolic risk factors in children and adolescents: the CASPIAN-V study

BMC Nutr. 2021 Nov 17;7(1):71. doi: 10.1186/s40795-021-00477-5.
Mostafa Qorbani 1 2, Motahar Heidari-Beni 3, Hanieh-Sadat Ejtahed 4, Gita Shafiee 5, Farid Goodarzi 2, Seyed Saeed Tamehri Zadeh 2, Majid Khademian 3, Nami Mohammadian Khonsari 6, Mohammad Esmaeil Motlagh 7, Hamid Asayesh 8, Mohammad Jabbari 2, Ramin Heshmat 2, Mehdi Ebrahimi 9, Roya Kelishadi 3

Background: Metabolic syndrome (MetS) starts from early life and is one of the important underlying factors for non-communicable diseases (NCDs) in adulthood. Controversial evidence exists on the role of vitamin D deficiency in increasing the risk of pediatric MetS.

Objective: This study aimed to assess the relationship between vitamin D level with MetS and its components in children and adolescents.

Methods: This nationwide cross-sectional study was performed as part of a surveillance program in Iran. Participants were 2596 students, aged 7 to 18 years, living in 30 provinces. In addition to filling questionnaires, a physical examination was conducted, and blood samples were collected. The serum concentration of 25-hydroxy vitamin D (25(OH)D) was measured using the direct competitive immunoassay chemiluminescence method.

Results: 2596 students with a mean age of 12.2 y (55.1% boys) were recruited. Prevalence of vitamin D deficiency and insufficiency in participants was 10.6% (n = 276), and 60.5% (n = 1570), respectively. The prevalence of MetS was higher in the vitamin D deficient group. Students with deficient vitamin D levels had higher odds of

  • MetS (OR: 4.25, 95%CI: 2.26-7.98),
  • abdominal obesity (OR: 2.24, 95%CI: 1.61-3.12),
  • low HDL-C (OR: 1.65, 95%CI: 1.18-2.30) and
  • high fasting blood sugar (OR: 2.56, 95%CI: 1.43-4.57)

in comparison to those with sufficient level of vitamin D.

Conclusion: Vitamin D deficiency was associated with increased odds of MetS and its components in the Iranian pediatric population. These findings underscore the importance of prevention and control of vitamin D deficiency in preventative programs against NCDs.


  1. Weihe P, Weihrauch-Bluher S. Metabolic syndrome in children and adolescents: diagnostic criteria, therapeutic options and perspectives. Curr Obes Rep. 2019;8(4):472–9. https://doi.org/10.1007/s13679-019-00357-x . - DOI - PubMed
  2. Taheri E, Saedisomeolia A, Djalali M, Qorbani M, Madani CM. The relationship between serum 25-hydroxy vitamin D concentration and obesity in type 2 diabetic patients and healthy subjects. J Diabetes Metab Disord. 2012;11(1):16. https://doi.org/10.1186/2251-6581-11-16 . - DOI - PubMed - PMC
  3. Saedisomeolia A, Taheri E, Djalali M, Moghadam AM, Qorbani M. Association between serum level of vitamin D and lipid profiles in type 2 diabetic patients in Iran. J Diabetes Metab Disord. 2014;13(1):7. https://doi.org/10.1186/2251-6581-13-7 . - DOI - PubMed - PMC
  4. Fu J, Han L, Zhao Y, Li G, Zhu Y, Li Y, et al. Vitamin D levels are associated with metabolic syndrome in adolescents and young adults: The BCAMS study. Clin Nutr (Edinburgh, Scotland). 2019;38(5):2161–7. - DOI
  5. Jari M, Qorbani M, Moafi M, Motlagh ME, Keikha M, Ardalan G, et al. Association of 25-hydroxy vitamin D levels with indexes of general and abdominal obesity in Iranian adolescents: the CASPIAN-III study. J Res Med Sci. 2015;20(2):122–6. - PubMed - PMC
  6. Kim S, Lim J, Kye S, Joung H. Association between vitamin D status and metabolic syndrome risk among Korean population: based on the Korean National Health and nutrition examination survey IV-2, 2008. Diabetes Res Clin Pract. 2012;96(2):230–6. https://doi.org/10.1016/j.diabres.2012.01.001 . - DOI - PubMed
  7. Murni IK, Sulistyoningrum DC, Oktaria V. Association of vitamin D deficiency with cardiovascular disease risk in children: implications for the Asia Pacific region. Asia Pac J Clin Nutr. 2016;25(Suppl 1):S8–S19. https://doi.org/10.6133/apjcn.122016.s1 . - DOI - PubMed
  8. Kim YS, Hwang JH, Song MR. The association between vitamin D deficiency and metabolic syndrome in Korean adolescents. J Pediatr Nurs. 2018;38:e7–e11. https://doi.org/10.1016/j.pedn.2017.11.005 . - DOI - PubMed
  9. Motlagh ME, Ziaodini H, Qorbani M, Taheri M, Aminaei T, Goodarzi A, et al. Methodology and early findings of the fifth survey of childhood and adolescence surveillance and prevention of adult noncommunicable disease: the CASPIAN-V study. Int J Prev Med. 2017;8(1):4. https://doi.org/10.4103/2008-7802.198915 . - DOI - PubMed - PMC
  10. Kelishadi R, Majdzadeh R, Motlagh ME, Heshmat R, Aminaee T, Ardalan G, et al. Development and evaluation of a questionnaire for assessment of determinants of weight disorders among children and adolescents: the Caspian-IV study. Int J Prev Med. 2012;3(10):699–705. - PubMed - PMC
  11. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006;84(1):18–28. https://doi.org/10.1093/ajcn/84.1.18 . - DOI - PubMed
  12. Alsharairi NA. Serum 25-hydroxyvitamin D is associated with obesity and metabolic parameters in US children. Public Health Nutr. 2020;23(7):1223–5. https://doi.org/10.1017/S1368980019001770 . - DOI - PubMed
  13. Fu Z, Xu C, Shu Y, Xie Z, Lu C, Mo X. Serum 25-hydroxyvitamin D is associated with obesity and metabolic parameters in US children. Public Health Nutr. 2020;23(7):1214–22. https://doi.org/10.1017/S1368980019001137 . - DOI - PubMed
  14. Reis JP, von Muhlen D, Miller ER 3rd, Michos ED, Appel LJ. Vitamin D status and cardiometabolic risk factors in the United States adolescent population. Pediatrics. 2009;124(3):e371–9. https://doi.org/10.1542/peds.2009-0213 . - DOI - PubMed
  15. Ha CD, Cho JK, Lee SH, Kang HS. Serum vitamin D, physical activity, and metabolic risk factors in Korean children. Med Sci Sports Exerc. 2013;45(1):102–8. https://doi.org/10.1249/MSS.0b013e31826c6956 . - DOI - PubMed
  16. Rafraf M, Hasanabad SK, Jafarabadi MA. Vitamin D status and its relationship with metabolic syndrome risk factors among adolescent girls in Boukan, Iran. Public Health Nutr. 2014;17(4):803–9. https://doi.org/10.1017/S1368980013003340 . - DOI - PubMed
  17. Ganji V, Zhang X, Shaikh N, Tangpricha V. Serum 25-hydroxyvitamin D concentrations are associated with prevalence of metabolic syndrome and various cardiometabolic risk factors in US children and adolescents based on assay-adjusted serum 25-hydroxyvitamin D data from NHANES 2001-2006. Am J Clin Nutr. 2011;94(1):225–33. https://doi.org/10.3945/ajcn.111.013516 . - DOI - PubMed
  18. Pacifico L, Anania C, Osborn JF, Ferraro F, Bonci E, Olivero E, et al. Low 25(OH)D3 levels are associated with total adiposity, metabolic syndrome, and hypertension in Caucasian children and adolescents. Eur J Endocrinol. 2011;165(4):603–11. https://doi.org/10.1530/EJE-11-0545 . - DOI - PubMed
  19. Pittas AG, Chung M, Trikalinos T, Mitri J, Brendel M, Patel K, et al. Systematic review: vitamin D and cardiometabolic outcomes. Ann Intern Med. 2010;152(5):307–14. https://doi.org/10.7326/0003-4819-152-5-201003020-00009 . - DOI - PubMed - PMC
  20. Grandi NC, Breitling LP, Brenner H. Vitamin D and cardiovascular disease: systematic review and meta-analysis of prospective studies. Prev Med. 2010;51(3–4):228–33. https://doi.org/10.1016/j.ypmed.2010.06.013 . - DOI - PubMed
  21. Wang L, Manson JE, Song Y, Sesso HD. Systematic review: vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med. 2010;152(5):315–23. https://doi.org/10.7326/0003-4819-152-5-201003020-00010 . - DOI - PubMed
  22. Parker J, Hashmi O, Dutton D, Mavrodaris A, Stranges S, Kandala NB, et al. Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis. Maturitas. 2010;65(3):225–36. https://doi.org/10.1016/j.maturitas.2009.12.013 . - DOI - PubMed
  23. Ju SY, Jeong HS, Kim DH. Blood vitamin D status and metabolic syndrome in the general adult population: a dose-response meta-analysis. J Clin Endocrinol Metab. 2014;99(3):1053–63. https://doi.org/10.1210/jc.2013-3577 . - DOI - PubMed
  24. Karkeni E, Bonnet L, Marcotorchino J, Tourniaire F, Astier J, Ye J, et al. Vitamin D limits inflammation-linked microRNA expression in adipocytes in vitro and in vivo: a new mechanism for the regulation of inflammation by vitamin D. Epigenetics. 2018;13(2):156–62. https://doi.org/10.1080/15592294.2016.1276681 . - DOI - PubMed - PMC
  25. Cianferotti L, Bertoldo F, Bischoff-Ferrari HA, Bruyere O, Cooper C, Cutolo M, et al. Vitamin D supplementation in the prevention and management of major chronic diseases not related to mineral homeostasis in adults: research for evidence and a scientific statement from the European society for clinical and economic aspects of osteoporosis and osteoarthritis (ESCEO). Endocrine. 2017;56(2):245–61. https://doi.org/10.1007/s12020-017-1290-9 . - DOI - PubMed - PMC
  26. Li Q, Dai Z, Cao Y, Wang L. Association of C-reactive protein and vitamin D deficiency with cardiovascular disease: a nationwide cross-sectional study from National Health and nutrition examination survey 2007 to 2008. Clin Cardiol. 2019;42(7):663–9. https://doi.org/10.1002/clc.23189 . - DOI - PubMed - PMC
  27. Schwetz V, Scharnagl H, Trummer C, Stojakovic T, Pandis M, Grubler MR, et al. Vitamin D supplementation and lipoprotein metabolism: a randomized controlled trial. J Clin Lipidol. 2018;12(3):588–96 e4. https://doi.org/10.1016/j.jacl.2018.03.079 . - DOI - PubMed
  28. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;117(4):503–11. https://doi.org/10.1161/CIRCULATIONAHA.107.706127 . - DOI - PubMed
  29. Zhao G, Ford ES, Li C, Kris-Etherton PM, Etherton TD, Balluz LS. Independent associations of serum concentrations of 25-hydroxyvitamin D and parathyroid hormone with blood pressure among US adults. J Hypertens. 2010;28(9):1821–8. https://doi.org/10.1097/HJH.0b013e32833bc5b4 . - DOI - PubMed
  30. Vaidya A, Forman JP. Vitamin D and hypertension: current evidence and future directions. Hypertension (Dallas, Tex : 1979). 2010;56(5):774–9. - DOI
  31. Salo A, Logomarsino JV. Relationship of vitamin D status and cardiometabolic risk factors in children and adolescents. Pediatr Endocrinol Rev. 2011;9(1):456–62. - PubMed
  32. Alaklabi AM, Alsharairi NA. Current evidence on vitamin D deficiency and metabolic syndrome in obese children: what does the evidence from Saudi Arabia tell us?. Children. 2018;5(1):11.
  33. Adikaram SGS, Samaranayake D, Atapattu N, Kendaragama K, Senevirathne JTN, Wickramasinghe VP. Prevalence of vitamin D deficiency and its association with metabolic derangements among children with obesity. BMC Pediatr. 2019;19(1):186. https://doi.org/10.1186/s12887-019-1558-8 . - DOI - PubMed - PMC

VitaminDWiki - Metabolic Syndrome

All items in category Metabolic Syndrome and Vitamin D 91 items

See also

VitaminDWiki studies Metabolic Syndrome and Youths

Metabolic Syndrome images from web

Image Image Image

Created by admin. Last Modification: Wednesday November 17, 2021 14:14:49 GMT-0000 by admin. (Version 3)
See any problem with this page? Report it (WORKS NOV 2021)